Evidence map›Paper›PMID 41735843›Full record

ArticleBMC primary care2026

Higher suicidality among primary care patients who have opioid use disorder and co-occurring depression and/or PTSD.

Miriam Komaromy, Lisa S Meredith, Maya Rabinowitz, Colleen McCullough, Lauren Kelly, Beth Ann Griffin, Sapna Mendon-Plasek, Katherine E Watkins

Registry-linked trialAbstract read
In one paragraph

Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04559893 (Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04559893 nacompletednot on this map

Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness

TypeinterventionalSponsorRANDRan2021 to 2024Enrolled729ConditionsOpioid-use Disorder, Addiction, Depression, Post-traumatic Stress DisorderArmsCollaborative Care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miriam KomaromyGrayken Center for Addiction, Boston Medical Center, Division of General Internal Medicine, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, 02118, USA.
Lisa S MeredithRAND, 1776 Main Street, Santa Monica, CA, 90407-2138, USA. seidel@rand.org.
Maya RabinowitzRAND, 20 Park Plaza, Suite 910, Boston, MA, 02116, USA.
Colleen McCulloughRAND, 1776 Main Street, Santa Monica, CA, 90407-2138, USA.
Lauren KellyRAND, 20 Park Plaza, Suite 910, Boston, MA, 02116, USA.
Beth Ann GriffinRAND, 1200 South Hayes Street, Arlington, VA, 22202-5050, USA.
Sapna Mendon-PlasekRAND, 20 Park Plaza, Suite 910, Boston, MA, 02116, USA.
Katherine E WatkinsRAND, 1776 Main Street, Santa Monica, CA, 90407-2138, USA.

Funding

NIMH NIH HHS U01MH121954
6 · The paper itself

Abstract

backgroundDepression and/or posttraumatic stress disorder (PTSD) commonly co-occur with opioid use disorder (OUD), and such co-occurring disorders (COD) are especially common among patients in primary care settings. Therefore, addressing the mental health needs of people with COD in primary care is essential.

methodsWe compared the characteristics of three groups of patients who screened positive for OUD and depression and/or PTSD: (OUD + depression, OUD + PTSD, and OUD + depression + PTSD) and examined how membership in these groups was associated with suicidality and treatment. We analyzed cross-sectional baseline survey data from a larger study of collaborative care for COD. 797 adult patients were seen in 17 primary care clinics that provide care for diverse uninsured and underinsured patients in New Mexico and California. Our key independent variable was COD group. Dependent variables were suicidal ideation and behavior; and receipt of treatments for COD 30 days prior to baseline.

resultsThe patient group with all three conditions was larger than the other groups with only two disorders (OUD + PTSD (no depression) or OUD + depression (no PTSD). Patients with all three disorders reported more severe OUD, depression, and PTSD symptoms and higher probability of suicidality. Patients with PTSD (with or without depression) were more likely to report receiving medication for OUD and mental health counseling compared to those with no PTSD, and those with OUD, PTSD, and depression were more likely to report receiving medication for mental health problems than those with just two disorders.

conclusionsHigher probabilities of suicidality and of receiving mental health treatment among those with all three disorders point to the need for identifying these individuals in primary care. TRIALS REGISTRATION: Clinicaltrials.gov, Identifiers, Registration Dates: NCT0455989; NCT04559893, September 8, 2020.

Indexed as

DepressionOpioid-Related DisordersPrimary Health CareStress Disorders, Post-TraumaticSuicidal IdeationSuicideAdultCaliforniaComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedNew MexicoCollaborative careDepressionIntegrating primary care and mental healthOpioid use disorderPrimary carePTSDSafety net Federally Qualified Health Centers (FQHCs)Suicidality

Identifiers

PMID41735843
PMCPMC13040686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.